Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

1
Player Avatar TerryHoodSr (60.36) Submitted: 1/4/2013 8:44:52 PM : Outperform Start Price: $86.43 AMGN Score: +15.99

TP 95

Featured Broker Partners


Advertisement